SIRT6 suppresses the transcription of Serpina12 through histone H3K9 deacetylation at its promoter, thereby reducing glucose uptake, lactate production, and aberrant lipid synthesis, ultimately limiting cancer cell proliferation and survival [59]. Here, SIRT6 is linked to cancer.